News-Medical.Net on MSN

How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?

By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...
Insurancenewsnet.com

New Hormones Study Findings Have Been Reported by Researchers at University of Michigan (Understanding Insurance Coverage Policies for Incretin Mimetics for Weight Management ...

2025 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Researchers detail new data in Drugs and Therapies - Hormones. According to news originating from Ann Arbor, ...
Yahoo

Zepbound vs. Wegovy: Comparing weight loss drugs

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...
Heartland

Use of Weight Loss Drugs Costly, Widespread

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic ...
The American Journal of Managed Care

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care. Their qualitative study, "Understanding ...